Abstract |
US military recruits receive benzathine penicillin prophylaxis because of endemicity of group A beta-hemolytic streptococcal (GABHS) infections. GABHS prevalence in Navy recruits receiving single-dose benzathine penicillin prophylaxis was assessed during spring and fall 1989 by culturing throat specimens from randomly selected groups of approximately 230 men before and 2, 4, and 7 weeks after prophylaxis and from men with pharyngitis diagnosed at sick call. Of 60 GABHS isolates, 75% were serotype M-3. The pharyngitis rate increased from 0.18% in the spring to 1.55% in the fall with a concurrent increase in serotype M-3 prevalence from 35% to 91%. The GABHS prevalence rate was three- to fourfold lower after prophylaxis. There were no cases of acute rheumatic fever (ARF) despite predominance of M-3, a rheumatogenic serotype. It was concluded that penicillin prophylaxis continues to be effective for control of GABHS infections and prevention of ARF in Navy recruits.
|
Authors | A D Heggie, M R Jacobs, P E Linz, D P Han, E L Kaplan, B Boxerbaum |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 166
Issue 5
Pg. 1006-13
(Nov 1992)
ISSN: 0022-1899 [Print] United States |
PMID | 1402011
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Drug Hypersensitivity
- Humans
- Male
- Military Personnel
- Penicillin G Benzathine
(immunology, therapeutic use)
- Pharyngitis
(microbiology)
- Pharynx
(microbiology)
- Prevalence
- Serotyping
- Streptococcal Infections
(epidemiology, microbiology, prevention & control)
- Streptococcus pyogenes
(classification, isolation & purification)
- United States
|